Baltimore is accusing the owners of Zyn nicotine pouches of targeting children with deceptive marketing practices, violating the city's Consumer Protection Ordinance.

Philip Morris stock jumped 6.9% after a strong Q1 earnings report that left Wall Street flicking its lighter in approval.

Changes to the U.S. regulatory landscape could dampen the ability to authorize new products AND enforce existing regulations.

Philip Morris International is lighting up Wall Street with impressive growth, driven by smoke-free alternatives like IQOS ...

Baltimore has sued a major nicotine manufacturer, alleging the company is marketing nicotine pouches to children and ...

Philip Morris (PM) thrives with smoke-free innovations like IQOS and Zyn, driving $15B in revenue and gaining investor ...

Philip Morris (PM) named a top consumer staple by Morgan Stanley, offering growth potential, defensive stability, and ...

This browser is no longer supported at MarketWatch. For the best MarketWatch.com experience, please update to a modern browser.

See AT&T Hedge Fund Trading Activity on TipRanks. Philip Morris rewarded shareholders with a quarterly dividend of $1.35 per ...

Philip Morris International will launch IQOS heated tobacco device in Fort Lauderdale, Florida, the second US city targeted ...

Under Ron Dennis, the McLaren team built a Formula One dynasty by running a racing outfit like a business. Here’s how they ...

BofA raised the firm’s price target on Philip Morris (PM) to $182 from $175 and keeps a Buy rating on the shares. Organic net sales, gross profit and operating income growth in the first quarter ...